These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28676094)

  • 1. Cultured epidermal stem cells in regenerative medicine.
    Jackson CJ; Tønseth KA; Utheim TP
    Stem Cell Res Ther; 2017 Jul; 8(1):155. PubMed ID: 28676094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa.
    De Rosa L; Secone Seconetti A; De Santis G; Pellacani G; Hirsch T; Rothoeft T; Teig N; Pellegrini G; Bauer JW; De Luca M
    Cell Rep; 2019 May; 27(7):2036-2049.e6. PubMed ID: 31091444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls.
    Tolar J; Wagner JE
    Exp Dermatol; 2012 Dec; 21(12):896-900. PubMed ID: 23016552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of caveolin-1 in epidermal stem cells during burn wound healing in rats.
    Yang R; Wang J; Zhou Z; Qi S; Ruan S; Lin Z; Xin Q; Lin Y; Chen X; Xie J
    Dev Biol; 2019 Jan; 445(2):271-279. PubMed ID: 30476483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regenerative potential of epithelial stem cells in tissue repair.
    Arandjelovic P; Kaur P
    Int J Biochem Cell Biol; 2014 Nov; 56():107-10. PubMed ID: 25467018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo gene therapy cures a blistering skin disease.
    Featherstone C; Uitto J
    Trends Mol Med; 2007 Jun; 13(6):219-22. PubMed ID: 17416553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flightless I over-expression impairs skin barrier development, function and recovery following skin blistering.
    Kopecki Z; Yang GN; Arkell RM; Jackson JE; Melville E; Iwata H; Ludwig RJ; Zillikens D; Murrell DF; Cowin AJ
    J Pathol; 2014 Apr; 232(5):541-52. PubMed ID: 24375017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate.
    Chermnykh E; Kalabusheva E; Vorotelyak E
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa.
    De Rosa L; Carulli S; Cocchiarella F; Quaglino D; Enzo E; Franchini E; Giannetti A; De Santis G; Recchia A; Pellegrini G; De Luca M
    Stem Cell Reports; 2014 Jan; 2(1):1-8. PubMed ID: 24511464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kindler syndrome.
    Lai-Cheong JE; McGrath JA
    Dermatol Clin; 2010 Jan; 28(1):119-24. PubMed ID: 19945624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and biosafety of human epidermal stem cell for wound repair: preclinical evaluation.
    Zhao X; Li X; Wang Y; Guo Y; Huang Y; Lv D; Lei M; Yu S; Luo G; Zhan R
    Stem Cell Res Ther; 2023 Jan; 14(1):4. PubMed ID: 36600269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a gene therapy clinical trial for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
    Rev Recent Clin Trials; 2006 May; 1(2):155-62. PubMed ID: 18473966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa.
    Tolar J; Blazar BR; Wagner JE
    Stem Cells; 2011 Jun; 29(6):900-6. PubMed ID: 21557391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human keratinocyte stem cells: From cell biology to cell therapy.
    Nanba D
    J Dermatol Sci; 2019 Nov; 96(2):66-72. PubMed ID: 31669183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone Marrow-Derived Stem Cells Migrate into Intraepidermal Skin Defects of a Desmoglein-3 Knockout Mouse Model but Preserve their Mesodermal Differentiation.
    Hünefeld C; Mezger M; Müller-Hermelink E; Schaller M; Müller I; Amagai M; Handgretinger R; Röcken M
    J Invest Dermatol; 2018 May; 138(5):1157-1165. PubMed ID: 29203359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy approaches for epidermolysis bullosa.
    Ferrari S; Pellegrini G; Mavilio F; De Luca M
    Clin Dermatol; 2005; 23(4):430-6. PubMed ID: 16023940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine.
    Pellegrini G; Rama P; Di Rocco A; Panaras A; De Luca M
    Stem Cells; 2014 Jan; 32(1):26-34. PubMed ID: 24038592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cells of the skin and cornea: their clinical applications in regenerative medicine.
    Proulx S; Fradette J; Gauvin R; Larouche D; Germain L
    Curr Opin Organ Transplant; 2011 Feb; 16(1):83-9. PubMed ID: 21150608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long and winding road that leads to a cure for epidermolysis bullosa.
    Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
    Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.